Related references
Note: Only part of the references are listed.Identification of the first potent, selective and bioavailable PPARα antagonist
Yalda Bravo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
The Nuclear Receptor Peroxisome Proliferator-activated Receptor-β/δ (PPARβ/δ) Promotes Oncogene-induced Cellular Senescence through Repression of Endoplasmic Reticulum Stress
Bokai Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies
Ganesha Rai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPAR-β/δ) Inhibits Human Breast Cancer Cell Line Tumorigenicity
Pei-Li Yao et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Site-specific activation of AKT protects cells from death induced by glucose deprivation
M. Gao et al.
ONCOGENE (2014)
Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ triad in regulation of reactive oxygen species signaling in brain
Stepan Aleshin et al.
BIOLOGICAL CHEMISTRY (2013)
PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia
Stephanie Tung et al.
BLOOD (2013)
Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling
Reginald M. Gorczynski et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
PPARδ Induces Estrogen Receptor-Positive Mammary Neoplasia through an Inflammatory and Metabolic Phenotype Linked to mTOR Activation
Hongyan Yuan et al.
CANCER RESEARCH (2013)
Desnutrin/ATGL Activates PPARδ to Promote Mitochondrial Function for Insulin Secretion in Islet β Cells
Tianyi Tang et al.
CELL METABOLISM (2013)
Tackling the Diversity of Triple-Negative Breast Cancer
Nicholas C. Turner et al.
CLINICAL CANCER RESEARCH (2013)
FoxO3 coordinates metabolic pathways to maintain redox balance in neural stem cells
Hyeonju Yeo et al.
EMBO JOURNAL (2013)
mda-7/IL-24 Expression Inhibits Breast Cancer through Upregulation of Growth Arrest-Specific Gene 3 (gas3) and Disruption of β1 Integrin Function
You-Jun Li et al.
MOLECULAR CANCER RESEARCH (2013)
Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion
T. Adhikary et al.
ONCOGENE (2013)
Cell Survival Signalling through PPARδ and Arachidonic Acid Metabolites in Neuroblastoma
Emma Bell et al.
PLOS ONE (2013)
Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response
R. Palorini et al.
CELL DEATH & DISEASE (2013)
A Comprehensive Nuclear Receptor Network for Breast Cancer Cells
Ralf Kittler et al.
CELL REPORTS (2013)
Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system
Teayoun Kim et al.
WORLD JOURNAL OF CARDIOLOGY (2013)
Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4
Combiz Khozoie et al.
BMC GENOMICS (2012)
Development of Improved PPARß/d Inhibitors
Philipp M. Toth et al.
CHEMMEDCHEM (2012)
Microenvironments and Cellular Characteristics in the Micro Tumor Cords of Malignant Solid Tumors
Chan Joo Yeom et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
A metabolic prosurvival role for PML in breast cancer
Arkaitz Carracedo et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
(Z)-2-(2-Bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): An Orally Bioavailable PPARβ/δ-Selective Ligand with Inverse Agonistic Properties
Sonja Lieber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson et al.
NATURE (2012)
A PML-PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance
Keisuke Ito et al.
NATURE MEDICINE (2012)
Vascular effects of prostacyclin: does activation of PPARδ play a role?
Zvonimir S. Katusic et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia
Jelena Tomic et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
PPARs and Lipid Ligands in Inflammation and Metabolism
Gregory S. Harmon et al.
CHEMICAL REVIEWS (2011)
VLDL Hydrolysis by Hepatic Lipase Regulates PPARδ Transcriptional Responses
Jonathan D. Brown et al.
PLOS ONE (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist
Barry G. Shearer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor β/δ Agonist
Simone Naruhn et al.
MOLECULAR PHARMACOLOGY (2010)
AMPK and PPARδ Agonists are exercise mimetics
Vihang A. Narkar et al.
CELL (2008)
PPARδ is a type 1 IFN target gene and inhibits apoptosis in T cells
Nadya al Yacoub et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Identification and characterization of a selective peroxisome proliferator-activated receptor β/δ (NR1C2) antagonist
Barry G. Shearer et al.
MOLECULAR ENDOCRINOLOGY (2008)
Transcriptional network governing the angiogenic, switch in human pancreatic cancer
Amir Abdollahi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PPARδ, but not PPARα, activates PGC-lα gene transcription in muscle
Elayne Hondares et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Calcineurin regulates skeletal muscle metabolism via coordinated changes in gene expression
Yun Chau Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Chromosome 6p amplification and cancer progression
Gda C. Santos et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Peroxisome proliferator-activated receptor δ (PPARδ) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis
M Pesant et al.
CARDIOVASCULAR RESEARCH (2006)
Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis
YJ Li et al.
ONCOGENE (2003)
Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway
N Di-Poï et al.
MOLECULAR CELL (2002)
Share Paper
